Cargando…
Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?
The coronavirus pandemic, known as coronavirus disease 2019 (COVID-19), is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus first identified in patients from Wuhan, China. Since December 2019, SARS-CoV-2 has spread swiftly...
Autores principales: | Bouazza, Belaid, Hadj-Said, Dihia, Pescatore, Karen A., Chahed, Rachid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801803/ https://www.ncbi.nlm.nih.gov/pubmed/33099990 http://dx.doi.org/10.4046/trd.2020.0101 |
Ejemplares similares
-
Chloroquine and COVID-19: role as a bitter taste receptor agonist?
por: Bouazza, B., et al.
Publicado: (2021) -
Assessment of asthma and chronic obstructive pulmonary disorder
por: Wiwanitkit, Viroj
Publicado: (2011) -
Asthma, chronic obstructive pulmonary disease, and pneumonia
por: Cydulka, Rita K., et al.
Publicado: (2011) -
Autophagy in asthma and chronic obstructive pulmonary disease
por: Barnes, Peter J., et al.
Publicado: (2022) -
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2020)